Top News

Road sign displaying the words Fast Track against a blue sky

RESEARCH

16 Jan 2026

FDA Fast Tracks Dual-Action MASH Drug: Is Momentum Back?

FDA grants two expedited reviews to a dual-action MASH drug, reviving interest in metabolic approaches without signaling a policy overhaul

Close-up of GLP-1 text under magnifying glass with obesity and diabetes terms

MARKET TRENDS

5 Feb 2026

Patients Take the Lead in US Metabolic Drug Pricing

PARTNERSHIPS

3 Feb 2026

AstraZeneca Brings AI In-House to Speed Drug Discovery

Latest News

INNOVATION
25 Feb 2026
Can AI Rethink How New Drugs Are Found?
PARTNERSHIPS
24 Feb 2026
Lilly Deepens AI Push in Obesity Drug Race
INVESTMENT
23 Feb 2026
Another Shot in the Obesity Gold Rush
MARKET TRENDS
19 Feb 2026
Precision Medicine Rises as Biomarkers Drive Change

Pfizer Steps Up Obesity Push With Metsera Deal

PARTNERSHIPS

17 Feb 2026

US drugmaker agrees multibillion-dollar acquisition to bolster metabolic pipeline and challenge leaders in weight-loss therapies

Close-up of a Novo-branded white pill on a reflective dark surface.

INNOVATION

25 Jun 2025

From Needle to Pill: The New Face of Obesity Treatment

Novo's amycretin pill shows big early weight-loss results, hinting at a future beyond injections.

RESEARCH

21 Jun 2025

Stem Cell Trial Offers Hope for Insulin-Free Diabetes

Vertex's zimislecel left most trial patients insulin-free after a year, but safety risks and scalability remain major hurdles

8 9

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.